Physician profile
Troy Leo
NPI 1629225701
$751.47
in general payments reported to CMS, 2019-2025
9 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $125 · 2021: $77.65 · 2023: $221 · 2024: $5.90 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $369.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $206.61 | 2019-2020 | |
| Janssen Scientific Affairs, LLC | $161.46 | 2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $124.25 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $77.65 | 2021 | |
| Abiomed | $69.04 | 2025 | |
| Heartflow, INC. | $54.92 | 2025 | |
| Janssen Pharmaceuticals, INC | $33.75 | 2023 | Xarelto |
| Siemens Medical Solutions USA, INC. | $17.89 | 2025 | Acuson Origin Diagnostic Ultrasound System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.90 | 2024 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Leo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.